Ekso Bionics Holdings Inc. Daily Stock Analysis

Daily Stock Analysis, EKSO, Ekso Bionics Holdings Inc, priceseries

Ekso Bionics Holdings Inc. Daily Stock Analysis
Stock Information
Open
2.50
Close
2.54
High
2.58
Low
2.50
Previous Close
2.52
Daily Price Gain
0.02
YTD High
3.15
YTD High Date
Jan 5, 2022
YTD Low
2.20
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.21
YTD Gain
-7.64%
52 Week High
7.53
52 Week High Date
Mar 17, 2021
52 Week Low
2.20
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-3.48
52 Week Gain
-57.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 17. 2017
48.90
Apr 3. 2017
52.88
11 Trading Days
8.14%
Link
LONG
Jun 12. 2017
18.90
Jul 5. 2017
30.99
16 Trading Days
63.99%
Link
LONG
Nov 10. 2017
22.95
Nov 29. 2017
38.10
12 Trading Days
66.03%
Link
LONG
Jan 2. 2019
21.30
Jan 28. 2019
24.87
17 Trading Days
16.77%
Link
LONG
Apr 13. 2020
3.17
May 1. 2020
3.63
14 Trading Days
14.61%
Link
LONG
May 22. 2020
3.26
Jun 8. 2020
4.19
10 Trading Days
28.46%
Link
LONG
Nov 19. 2020
4.71
Dec 7. 2020
5.46
11 Trading Days
15.94%
Link
LONG
Dec 21. 2020
5.64
Dec 29. 2020
5.97
5 Trading Days
5.94%
Link
LONG
Jan 4. 2021
6.33
Jan 27. 2021
8.72
16 Trading Days
37.71%
Link
LONG
Feb 2. 2021
9.16
Feb 9. 2021
10.20
5 Trading Days
11.34%
Link
Company Information
Stock Symbol
EKSO
Exchange
NasdaqCM
Company URL
http://www.eksobionics.com
Company Phone
510-984-1761
CEO
Thomas Looby
Headquarters
California
Business Address
1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND, CA 94804
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001549084
About

Ekso Bionics Holdings, Inc. designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military, and consumer markets. The company operates through Engineering Services and Medical business segments. The Engineering services segment engages in research and development service arrangements, technology license agreements, and government grants. The Medical service segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.

Description

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation to develop products for military applications, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading